:

Jana Kotulová1,2, Klára Baďurová1,2, Zuzana Chyra1,2

  • 1Department of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.

Biomarker research
|July 2, 2025
PubMed
概括

新兴的免疫点为多发性骨髓瘤治疗提供了新的希望,通过克服抗原逃逸和瘤外毒性. 像LILRB4和SEMA4A这样的有希望的标显示出下一代免疫疗法的潜力,改善了患者的治疗结果.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K